Search

everythinglearnresearchcommunity

for

Search:↓

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Ruxolitinib cream may help treat severe hair loss in children.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Dupilumab may help treat alopecia areata without needing high IgE levels.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Rituximab can cause skin issues, but baricitinib may help improve them.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Adding a second method to PROTACs could improve cancer treatment.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

The man was diagnosed with stage III multiple myeloma and treated to improve kidney function.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Dupilumab may help regrow hair in people with atopic dermatitis.

PRAME helps distinguish between benign and malignant skin cells in most cases.

Lenalidomide helps hair follicle stem cells turn into melanocytes, which may improve repigmentation in vitiligo.

Photobiomodulation therapy effectively promotes hair regrowth and improves quality of life in alopecia areata without side effects.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.